Raymond Mak MD, is a Professor of Radiation Oncology at Harvard Medical School and the Department of Radiation Oncology at Mass General Brigham/Dana-Farber Cancer Institute. He is a faculty leader in the Artificial Intelligence in Medicine Program at Mass General Brigham.
Dr. Mak’s clinical focus includes treatment of thoracic malignancies, stereotactic body radiation therapy and novel image-guided radiation therapy techniques. He led the implementation of MR-guided radiation therapy program at BWH/DFCI in 2019.
His research interests focus on developing imaging biomarkers to predict radiation therapy response, outcomes, and toxicity for lung cancer patients, and clinically applying artificial intelligence techniques to automate radiation therapy planning and improve risk stratification.
Disclosures:
- Employment: Brigham and Women's Hospital:Associate Professor:Employee
- Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: To present ;ViewRay: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: 10/31/23 ;Pfizer: Consultant, Honoraria-End Date: To present ;Sio Capital Mgmt: Consultant, Honoraria-End Date: 10/13/22 ;Varian Medical Systems: Consultant, Honoraria-End Date: 12/1/2022 ;Siemens: Research Grant
- Ownership: Facial health recognition AI algorithms:Copyright
- Leadership: none